A large retrospective cohort study from Weill Cornell Medical College - examining 255 patients (92% women, mean age 64) with DXA scans before and after starting semaglutide or tirzepatide - found that GLP-1 receptor agonist use was associated with greater annualized total hip bone loss in patients without diabetes, while patients with diabetes showed bone loss more comparable to non-users
Keep them in their original labeled packaging and carry a copy of your prescription
Benefits of GLP-1 Encourages Significant Weight Loss Curbs Hunger Cravings Stabilizes Blood Sugar (Glycemic) Levels Reduces Cardiovascular Health Risks Reduces Musculoskeletal Inflammation Improves Body Image and Self-Esteem Monthly Food Savings Lowers Risk of Drug and Alcohol Addiction & More
Kong X, Liu H, He X, Sun Y, Ge W
Research-only peptides are typically produced in bulk overseas with no FDA oversight, which means theres no guarantee of whats actually in the vial
Every GLP-1 receptor agonist causes delayed gastric emptying